Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Total Current Liabilities (2021 - 2025)

Medicinova (MNOV) has disclosed Total Current Liabilities for 7 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities changed N/A to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 million, a N/A change, with the full-year FY2025 number at $3.8 million, changed N/A from a year prior.
  • Total Current Liabilities was $3.8 million for Q4 2025 at Medicinova, up from $3.3 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $4.5 million in Q3 2022 to a low of $1.8 million in Q1 2021.
  • A 5-year average of $3.0 million and a median of $2.8 million in 2023 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: surged 62.54% in 2022, then tumbled 38.13% in 2023.
  • Medicinova's Total Current Liabilities stood at $2.8 million in 2021, then surged by 59.85% to $4.5 million in 2022, then decreased by 27.59% to $3.3 million in 2023, then dropped by 20.8% to $2.6 million in 2024, then soared by 46.23% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Total Current Liabilities are $3.8 million (Q4 2025), $3.3 million (Q3 2025), and $2.6 million (Q2 2025).